NICHOLSON NUR (Chief Technical Officer) sold 9.8% of their position (7.72K shares) of APELLIS PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $168.1K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/23/2026ACC: 0001492422-26-000056
Officer· Chief Technical Officer
Since Sep 2020
-7.72K
Net shares
Net seller
$168.1K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
7.72K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−7.72K
Price / share
$21.77
Trade value
$168.14K
% of position
9.8%
1/22/2026
78.84K→71.12K
Total
Net shares
−7.72K
Net value
-$168.14K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/22/2026 | S · Sale | −7.72K | $21.77 | $168.14K | 9.8% | 78.84K | 71.12K |
| Total | −7.72K | -$168.14K | ||||||
Derivative Transactions0
No derivative transactions reported